Medicare Enrolled

Mei An Tonette Ty Arias

Rheumatology · Mesquite, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1600 REPUBLIC PKWY STE 200, Mesquite, TX 75150
9722882600
Registered in NPPES since 2012
NPI: 1467709485 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Ty Arias from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Ty Arias? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Ty Arias

Mei An Tonette Ty Arias is a rheumatology specialist in Mesquite, TX, with 14 years of NPI registration. Based on federal Medicare data, Ty Arias performed 25,666 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Ty Arias received a total of $17,238 from 43 pharmaceutical and/or device companies across 883 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Ty Arias is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ Top 30% volume in TX $17,238 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
25,666
Medicare services
Top 30% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
25,200 $4 $13
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
165 $88 $270
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
108 $58 $189
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
83 $101 $345
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
58 $22 $110
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $57 $184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
98.8% medium
0.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$17,238
Total received (2018-2024)
Avg $2,463/year across 7 years
Top 20% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
883
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,796
2023
$2,422
2022
$3,027
2021
$1,827
2020
$1,036
2019
$4,093
2018
$2,036

Payments by company (2024)

ABBVIE INC.
$572
Amgen Inc.
$543
Novartis Pharmaceuticals Corporation
$413
GlaxoSmithKline, LLC.
$234
AstraZeneca Pharmaceuticals LP
$206
UCB, Inc.
$200
PFIZER INC.
$174
Radius Health, Inc.
$104
Organon Llc
$96
Lilly USA, LLC
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Janssen Biotech, Inc.
$43
Aurinia Pharma U.S., Inc.
$32
Fresenius Kabi USA, LLC
$32
Octapharma USA, Inc.
$23
HOSPIRA, INC.
$12
Top 3 companies account for 54.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,056
CSL Behring
$1,858
ABBVIE INC.
$1,848
AbbVie Inc.
$1,431
Novartis Pharmaceuticals Corporation
$1,255
AbbVie, Inc.
$917
UCB, Inc.
$849
AstraZeneca Pharmaceuticals LP
$764
GlaxoSmithKline, LLC.
$729
Horizon Therapeutics plc
$610
PFIZER INC.
$593
E.R. Squibb & Sons, L.L.C.
$489
Janssen Biotech, Inc.
$448
Mallinckrodt Hospital Products Inc.
$358
Genentech USA, Inc.
$341
Lilly USA, LLC
$294
Organon LLC
$280
Aurinia Pharma U.S., Inc.
$272
Celgene Corporation
$225
Radius Health, Inc.
$208
GENZYME CORPORATION
$206
Horizon Pharma plc
$181
Boehringer Ingelheim Pharmaceuticals, Inc.
$174
Janssen Scientific Affairs, LLC
$144
Takeda Pharmaceuticals U.S.A., Inc.
$121
Organon Llc
$96
Vertical Pharmaceuticals, LLC
$83
Mallinckrodt LLC
$47
SOBI, INC
$41
BioDelivery Sciences International, Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$36
Fresenius Kabi USA, LLC
$32
Mallinckrodt Enterprises LLC
$29
Sandoz Inc.
$27
Alexion Pharmaceuticals, Inc.
$24
Ironwood Pharmaceuticals, Inc
$23
Octapharma USA, Inc.
$23
Antares Pharma, Inc.
$22
Assertio Therapeutics, Inc.
$17
Medtronic, Inc.
$16
Merck Sharp & Dohme Corporation
$12
HOSPIRA, INC.
$12
MEDAC PHARMA, INC.
$12
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · Bimzelx · COSENTYX · Cimzia · DUZALLO · EVENITY · Enbrel · Evekeo · FORTEO · Gralise · HADLIMA · HUMIRA · HYRIMOZ · Hizentra · Horizant · Humira · IDACIO · INTELLIS ADAPTIVESTIM · KEVZARA · KINERET · KRYSTEXXA · Kineret · LORZONE · LUPKYNIS · LYRICA · METHYLPHENIDATE 72 · NEXPLANON · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Mesquite?
Compare rheumatologists in the Mesquite area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
92
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
DALLAS REGIONAL MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Ty Arias is a mixed practice specialist, with above-average Medicare volume (top 30% in TX).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Ty Arias experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Ty Arias performed 25,200 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Ty Arias receive payments from pharmaceutical companies?
Yes. Ty Arias received a total of $17,238 from 43 companies across 883 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Ty Arias's costs compare to other rheumatologists in Mesquite?
Ty Arias's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Ty Arias) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →